» Articles » PMID: 12160140

Change of Oxygen Pressure in Glioblastoma Tissue Under Various Conditions

Overview
Journal J Neurooncol
Publisher Springer
Date 2002 Aug 6
PMID 12160140
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Measurement of oxygen pressure (pO2) in tumor tissue is important, because pO2 is a major factor for radiosensitivity in malignant glioma treatment. We attempted to elucidate the changes in pO2 level in glioblastoma tissue of patients under various conditions. Eighteen patients with newly diagnosed glioblastoma were recruited to this study. Disposable Clark-type electrodes were inserted using CT guided stereotactic surgery under local anesthesia and left in the intra- and peritumoral regions. pO2 was measured in patients under conditions of being awake and asleep, inhaling 100% O2, being administered osmotic diuretics and following hyperbaric oxygen exposure (HBO). Peritumoral tissue had a significantly higher pO2 value in both awake and sleeping patients. O2 inhalation could not significantly increase the pO2 level, whereas administration of osmotic diuretics induced an increase in pO2 levels in peritumoral tissue alone. The pO2 levels were significantly increased in both regions after HBO, and a high pO2 level was maintained until 15 min after HBO in both regions. It is possible that the pO2 level in peritumoral tissue is affected by intracranial pressure, whereas that in the intratumoral tissue is usually low. HBO was the optimal procedure for oxygenation, but its benefit was reduced over time.

Citing Articles

Establishment of a novel benign meningioma cell line spontaneously immortalized under hypoxic conditions.

Ishikawa T, Matsuda M, Ishikawa H, Toyomura J, Ohyama A, Sakamoto N Hum Cell. 2024; 38(1):22.

PMID: 39612090 DOI: 10.1007/s13577-024-01151-1.


Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments.

Kennedy P, Arvindam U, Phung S, Ettestad B, Feng X, Li Y Sci Adv. 2024; 10(44):eadn1849.

PMID: 39475618 PMC: 11524192. DOI: 10.1126/sciadv.adn1849.


Key Genes Involved in the Beneficial Mechanism of Hyperbaric Oxygen for Glioblastoma and Predictive Indicators of Hyperbaric Oxygen Prolonging Survival in Glioblastoma Patients.

Ren Z, Wang R, Wang C, Ren X, Li D, Liu Y Curr Med Sci. 2024; 44(5):1036-1046.

PMID: 39446287 DOI: 10.1007/s11596-024-2934-7.


Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments.

Feldman L Front Immunol. 2024; 15:1384249.

PMID: 38994360 PMC: 11238147. DOI: 10.3389/fimmu.2024.1384249.


Biosensor-Enhanced Organ-on-a-Chip Models for Investigating Glioblastoma Tumor Microenvironment Dynamics.

Thenuwara G, Javed B, Singh B, Tian F Sensors (Basel). 2024; 24(9).

PMID: 38732975 PMC: 11086276. DOI: 10.3390/s24092865.


References
1.
Brown J . Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol. 1979; 52(620):650-6. DOI: 10.1259/0007-1285-52-620-650. View

2.
Kohshi K, Kinoshita Y, Imada H, Kunugita N, Abe H, Terashima H . Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas. Br J Cancer. 1999; 80(1-2):236-41. PMC: 2363018. DOI: 10.1038/sj.bjc.6690345. View

3.
Haffty B, Hurley R, Peters L . Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck: results of a randomized clinical trial. Cancer J Sci Am. 1999; 5(6):341-7. View

4.
Moringlane J . Measurement of oxygen partial pressure in brain tumors under stereotactic conditions. Adv Exp Med Biol. 1994; 345:471-7. DOI: 10.1007/978-1-4615-2468-7_63. View

5.
Kinoshita Y, Kohshi K, Kunugita N, Tosaki T, Yokota A . Preservation of tumour oxygen after hyperbaric oxygenation monitored by magnetic resonance imaging. Br J Cancer. 2000; 82(1):88-92. PMC: 2363207. DOI: 10.1054/bjoc.1999.0882. View